<DOC>
	<DOC>NCT00486473</DOC>
	<brief_summary>To show if one MRI contrast agent is better than another one in the diagnosis of malignant breast lesions compared to histopathology</brief_summary>
	<brief_title>Multihance Versus Magnevist in Breast MRI</brief_title>
	<detailed_description />
	<criteria>Provides written informed consent Female Age 18 years or older Suspicious or known breast lesion based on results from mammography or ultrasound Planned to undergo histological diagnosis of breast lesion by having a non surgical biopsy or breast surgery within 30 days after the MRI exam Body weight &gt; 100 kg Pregnant or lactating Server or endstage organ failure Moderate to severe renal impairment Undergoing radiotherapy or completed radiotherapy in the last 18 months Chemotherapy within 6 months of the 1st MRI exam</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>